We have sent a letter to Senate Health, Education, Labor and Pensions (HELP) Committee leadership that highlights the implications of the Verifying Accurate Leading-edge IVCT Development (VALID) Act. Because the bill would modify the regulatory framework for laboratory developed tests, the VALID Act could have serious unintended consequences for children’s health and children’s hospitals. We are asking the committee to address those concerns before advancing the Senate FDA user fee package legislation that includes the VALID Act.
VALID Act Letter
We sent a letter to Senate HELP Committee leadership to highlight the implications of the VALID Act.
Related Content
Children's Hospital Association's 2024 End of Year Letter to Congress
CHA's End of Year Priorities
High-Cost Therapies for Pediatrics
Children's Hospital Association's 2024 End of Year Letter to Congress
The letter highlights CHA's end of year priorities and asks Congress to take action to sustain children’s hospitals’ ability to provide care to our nation’s children.
Nov. 20, 2024
CHA's End of Year Priorities
CHA asks Congress to take action to sustain children’s hospitals’ ability to provide care to our nation’s children.
Nov. 20, 2024
High-Cost Therapies for Pediatrics
Pediatric HCTs are innovative and lifesaving or life-altering treatments for children with chronic, rare, and complex conditions.
Sep. 06, 2024
